Stephen Tyring
Physician · Mays MD Pa
Credentials: · · · · ·
History
Research
Secukinumab in plaque psoriasis--results of two phase 3 trials
New England Journal of Medicine · 2014 · 1,626 citations
The Lancet · 2006 · First of 12 authors · 851 citations
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
Journal of the American Academy of Dermatology · 2008 · 699 citations
- RM
36 papers
- JW
28 papers · 25 as a resident
26 papers · 7 as a resident
- HN
25 papers · 1 as a resident
- NM
25 papers · 3 as a resident
- CD
21 papers · 21 as a resident
20 papers · 20 as a resident
- SA
19 papers · 7 as a resident
Grants
- 2003–2006
Genetic Resistance to Oncogenic Human Papillomaviruses
National Cancer Institute · R03
Contact PI · $141K · University of Texas Hlth Sci Ctr Houston
- 1997–2002
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $3.9M · University of Texas Med Br Galveston
- 1989–1992
Mechanisms of Interferon Action Against Papillomaviruses
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $372.4K · University of Texas Med Br Galveston
Clinical trials
- 2026–2027
Photodynamic Therapy For Onychomycosis
Principal investigator · Recruiting · Phase 1
The University of Texas Health Science Center, Houston
- 2010–2011
Principal investigator · Completed · Phase 3
LEO Pharma
- 2007–2009
A Phase 2b Trial of EPB-348 for the Treatment of Herpes Zoster
Principal investigator · Completed · Phase 2
Epiphany Biosciences
- 2002–2007
Reduction of Postherpetic Neuralgia in Herpes Zoster
Principal investigator · Completed
Center for Clinical Studies, Texas